Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies

Effect of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone (R-A-A) system was evaluated in 0 normal subjects and 11 hypertensive patients with various etiologies. Captopril was administered orally to normal healthy subjects and hypertensive patients on unrestricted...

Full description

Saved in:
Bibliographic Details
Published inNihon Jinzo Gakkai shi Vol. 21; no. 11; pp. 1185 - 1192
Main Authors Kumahara, Yuichi, Higaki, Jitsuo, Maruyama, Anna, Takeshi, Hata, Mikami, Hiroshi, Naka, Toru, Ogihara, Toshio, Kanda, Takao, Gotoh, Motoki
Format Journal Article
LanguageJapanese
Published Japan Japanese Society of Nephrology 01.11.1979
Subjects
Online AccessGet full text
ISSN0385-2385
1884-0728
DOI10.14842/jpnjnephrol1959.21.11_1185

Cover

More Information
Summary:Effect of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone (R-A-A) system was evaluated in 0 normal subjects and 11 hypertensive patients with various etiologies. Captopril was administered orally to normal healthy subjects and hypertensive patients on unrestricted diet. Blood pressure was monitored for 4 hours. Blood was drawn at 0, 30 min., 1, 2, 3 and 4 hours for analysis of plasma renin activity (PRA), angiotensin I concentration (AI) and aldosterone concentration (PAC). Angiotensin II analogue (AIIA) test was done in each sub-jects after sodium depletion (40 mg f urosemide administration daily and mild sodium restricted diet for 3 days) Captopril in a dose of 100 mg caused no blood pressure change, increased PRA, AI and decreased PAC in normal subjects. When captopril was administered to patients with renovascular or malig-nant hypertension, blood pressure fell significantly for 4 hours, PRA and Al increased and PAC decreased for 4 hours. In low reninemic patients these paramenters showed little change. In all the subjects studied, change in mean blood pressure was inversely correlated with pre-treatment PRA value (y=-1.4×-2.8, r=0.85, p>0.001). Magnitude of blood pressure reduction by captopril was significantly correlated with that induced by angiotensin II antagonist (y=0.8×-5.0, r=0.93, p>0.001). From the results obtained, it is concluded that the acute blood pressure lowering effect of captopril in hyperreninemic hypertensive patients closely related to its effect on the suppression of R-A-A system. It may be useful to monitor the acute phase response of captopril to provide a prediction for the effectiveness of long term treatment of hypertension.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0385-2385
1884-0728
DOI:10.14842/jpnjnephrol1959.21.11_1185